Comparing the renal safety of isoosmolar versus low-osmolar contrast medium by renal biomarkers N-acetyl-β-d-glucosaminidase and endothelin

Angiology

Volumn 65, Issue 2, 2014, Pages 108-112

  Semerci, Tuna ^a   Çuhadar, Serap ^b   Akçay, Filiz Akyildiz ^c   Aydin, Tuǧba Kantaroǧlu ^d   Atay, Ayşenur ^b   Köseoǧlu, Mehmet ^b   Bayata, Serdar ^b  

^a Afyon Sandikli State Hospital   (Turkey)

^b ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c MERSIN STATE HOSPITAL   (Turkey)

^d Karaman State Hospital   (Turkey)

Author keywords

contrast agents; contrast induced nephropathy; coronary angiography; endothelins

Indexed keywords

ACETYLCYSTEINE; BIOLOGICAL MARKER; CREATININE; ENDOTHELIN; IODIXANOL; IOPAMIDOL; ISOTONIC SOLUTION; N ACETYL BETA GLUCOSAMINIDASE;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; DRUG SAFETY; FEMALE; HUMAN; KIDNEY FUNCTION; LOW RISK POPULATION; MALE; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; STABLE ANGINA PECTORIS; UREA NITROGEN BLOOD LEVEL; URINALYSIS; URINE; YOUNG ADULT;

EID: 84891879561     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319712469094     Document Type: Article

References (29)

1. Heinrich MC, Häberle L, Müller V, Bautz W, Uder M. Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low osmolar contrast media: meta-analysis of randomized controlled trials. Radiology. 2009 ; 250 (1). 68-86
2. Perrin T, Descombes E, Cook S. Contrast-induced nephropathy in invasive cardiology. Swiss Med Wkly. 2012 ; 142: w13608
3. Gupta R, Bang TJ. Prevention of contrast-induced nephropathy (CIN) in interventional radiology practice. Semin Intervent Radiol. 2010 ; 27 (4). 348-359
4. Thomson VS, Narayanan K, Singh JC. Contrast induced nephropathy in urology. Indian J Urol. 2009 ; 25 (4). 437-445
5. Huang SS, Huang PH, Wu TC, Chen JW, Lin SJ. Association of serum bilirubin with contrast-induced nephropathy and future cardiovascular events in patients undergoing coronary intervention. PLoS One. 2012 ; 7 (8). e42594
6. Fung JW, Szeto CC, Yu CM. Preventing contrast nephropathy in catheter laboratory. Heart. 2007 ; 93 (6). 654-655
7. Itoh Y, Yano T, Sendo T, Oishi R. Clinical and experimental evidence for prevention of acute renal failure induced by radiographic contrast media. J Pharmacol Sci. 2005 ; 97 (4). 473-488
8. Anarat A, Duman N, Noyan N, Kibar M, Anarat R. The role of endothelin in radiocontrast nephropathy. Int Urol Nephrol. 1997 ; 29 (5). 609-613
9. Ren L, Ji J, Fang Y, et al. Assessment of urinary N-acetyl-β- glucosaminidase as an early marker of contrast-induced nephropathy. J Int Med Res. 2011 ; 39 (2). 647-653
10. Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005 ; 16 (11). 3365-3370
11. Barrett BJ, Katzberg RW, Thomsen HS, et al. Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol. Invest Radiol. 2006 ; 41 (11). 815-821
12. Zhang Y, Wang J, Yang X, et al. The serial effect of iodinated contrast media on renal hemodynamics and oxygenation as evaluated by ASL and BOLD MRI. Contrast Media Mol Imaging. 2012 ; 7 (4). 418-425
13. Ideé JM, Lancelot E, Berthommier C, Couturier-Goulas V, Vazin V, Corot C. Effects of non-ionic monomeric and dimeric iodinated contrast media on renal and systemic haemodynamics in rats. Fundam Clin Pharmacol. 2000 ; 14 (1). 11-18
14. Lock EA. Sensitive and early markers of renal injury: where are we and what is the way forward?. Toxicol Sci. 2010 ; 116 (1). 1-4
15. Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group, KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl. 2012 ; 2: 1-138
16. Paraskevas KI, Giannoukas AD, Kotsikoris I, Mikhailidis DP. Contrast-induced nephropathy and the vascular patient. Angiology. 2010 ; 61 (8). 721-723
17. Hussain N, Al Otaibi T, Nampoory MRN. Contrast-media nephropathy: in depth review. Saudi J Kidney Dis Transpl. 2008 ; 19 (2). 174-182
18. Han WK, Waikar SS, Johnson A, et al. Urinary biomarkers in the early diagnosis of acute kidney injury. Kidney Int. 2008 ; 73 (7). 863-869
19. Feldkamp T, Baumgart D, Elsner M, et al. Nephrotoxicity of iso-osmolar versus low-osmolar contrast media is equal in low risk patients. Clin Nephrol. 2006 ; 66 (5). 322-330
20. Waring WS, Moonie A. Earlier recognition of nephrotoxicity using novel biomarkers of acute kidney injury. Clin Toxicol (Phila). 2011 ; 49 (8). 720-728
21. Shaker OG, El-Shehaby A, El-Khatib M. Early diagnostic markers for contrast nephropathy in patients undergoing coronary angiography. Angiology. 2010 ; 61 (8). 731-736
22. McCullough PA, Adam A, Becker CR, et al. Epidemiology and prognostic implications of contrast-induced nephropathy. Am J Cardiol. 2006 ; 98 (6A). 5K - 13K
23. Freeman RV, O'Dunnell M, Share D, et al. Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. Am J Cardiol. 2002 ; 90 (10). 1068-1073
24. Solomon RJ, Mehran R, Natarajan MK, et al. Contrast-induced nephropathy and long-term adverse effects: cause and effect?. Clin J Am Soc Nephrol. 2009 ; 4 (7). 1162-1169
25. Nguyen SA, Suranyi P, Ravenel JG, et al. Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: effect on kidney function. Radiology. 2008 ; 248 (1). 97-105
26. Clark BA, Kim D, Epstein FH. Endothelin and atrial natriuretic peptide levels following radiocontrast exposure in humans. Am J Kidney Dis. 1997 ; 30 (1). 82-86
27. Ozhan H, Erden I, Ordu S, et al. Efficacy of short-term high-dose atorvastatin for prevention of contrast-induced nephropathy in patients undergoing coronary angiography. Angiology. 2010 ; 61 (7). 711-714
28. Sadat U, Walsh SR, Norden AG, Gillard JH, Boyle JR. Does oral N-acetylcysteine reduce contrast-induced renal injury in patients with peripheral arterial disease undergoing peripheral angiography? A randomized-controlled study. Angiology. 2011 ; 62 (3). 225-230
29. Ozcan EE, Guneri S, Akyildiz B, et al. Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy: a comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial. Am Heart J. 2007 ; 154 (3). 539-544